5,422 Shares in HCA Healthcare, Inc. $HCA Bought by Silvant Capital Management LLC

Silvant Capital Management LLC purchased a new position in HCA Healthcare, Inc. (NYSE:HCA) in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 5,422 shares of the company’s stock, valued at approximately $2,114,000.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Nomura Asset Management Co. Ltd. boosted its stake in HCA Healthcare by 6.2% during the fourth quarter. Nomura Asset Management Co. Ltd. now owns 64,237 shares of the company’s stock valued at $29,990,000 after buying an additional 3,724 shares during the last quarter. Advisors Capital Management LLC increased its holdings in shares of HCA Healthcare by 61.5% in the 4th quarter. Advisors Capital Management LLC now owns 6,836 shares of the company’s stock worth $3,192,000 after buying an additional 2,604 shares during the last quarter. Arrowstreet Capital Limited Partnership boosted its stake in HCA Healthcare by 11.9% during the fourth quarter. Arrowstreet Capital Limited Partnership now owns 2,311,112 shares of the company’s stock worth $1,078,966,000 after buying an additional 245,887 shares during the period. Liberty Wealth Management LLC bought a new stake in HCA Healthcare in the fourth quarter worth about $1,905,000. Finally, Sunbelt Securities Inc. boosted its stake in shares of HCA Healthcare by 171.7% during the first quarter. Sunbelt Securities Inc. now owns 6,242 shares of the company’s stock valued at $2,954,000 after purchasing an additional 3,945 shares during the period. 62.73% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several brokerages have weighed in on HCA. Argus lowered their target price on HCA Healthcare from $560.00 to $500.00 and set a “buy” rating for the company in a report on Monday, May 4th. Weiss Ratings downgraded shares of HCA Healthcare from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Tuesday, June 9th. Oppenheimer reduced their price objective on shares of HCA Healthcare from $520.00 to $485.00 and set an “outperform” rating for the company in a research note on Monday, July 27th. Truist Financial cut their price target on HCA Healthcare from $535.00 to $495.00 and set a “buy” rating on the stock in a report on Monday, July 27th. Finally, Barclays dropped their price objective on HCA Healthcare from $402.00 to $387.00 and set an “equal weight” rating on the stock in a research report on Monday, July 27th. Fourteen equities research analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, HCA Healthcare presently has a consensus rating of “Moderate Buy” and an average price target of $462.64.

HCA Healthcare Trading Down 0.2%

Shares of HCA Healthcare stock opened at $406.33 on Friday. HCA Healthcare, Inc. has a 12-month low of $353.99 and a 12-month high of $556.52. The firm’s 50 day simple moving average is $396.32 and its two-hundred day simple moving average is $444.25. The firm has a market capitalization of $87.97 billion, a price-to-earnings ratio of 13.60, a PEG ratio of 1.41 and a beta of 1.10.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings results on Friday, July 24th. The company reported $7.59 earnings per share for the quarter, beating the consensus estimate of $7.56 by $0.03. The firm had revenue of $20.23 billion during the quarter, compared to analyst estimates of $19.76 billion. HCA Healthcare had a negative return on equity of 244.79% and a net margin of 8.77%.HCA Healthcare’s revenue for the quarter was up 8.7% compared to the same quarter last year. During the same quarter in the previous year, the business earned $6.84 EPS. On average, sell-side analysts predict that HCA Healthcare, Inc. will post 29.47 EPS for the current fiscal year.

HCA Healthcare Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Wednesday, September 30th. Stockholders of record on Wednesday, September 16th will be paid a $0.78 dividend. The ex-dividend date of this dividend is Wednesday, September 16th. This represents a $3.12 dividend on an annualized basis and a dividend yield of 0.8%. HCA Healthcare’s payout ratio is currently 10.45%.

About HCA Healthcare

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.